To Conduct a Scientific Study of a Polyherbal Formulation â??IMMURISEâ?? for subjective improvement on the nCOVID-19 positive individuals

Gujarat University0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1.Able and willing to comply with the protocol, including availability for all scheduled study visits.
•2.Male and Female patients aged from 18 years to 60 years old (both inclusive).
•3.Willing and able to provide written informed consent prior to performing study procedures by the subject or legal guardian willing and able to provide written informed consent prior to performing study procedures
•4.Patients with Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)-2 infection confirmed by RT Polymerase chain reaction (RT-PCR) test between 1 and 120 Hours before randomization
•5.Currently hospitalized or home quarantined and requiring medical care for COVID-19
•6.Peripheral capillary oxygen saturation (SpO2) > 90% on room air at screening (without CIPAP/BIPAP support)
•7.Radiographic evidence of pulmonary infiltrates
•8.Altered Haematological and/or Biochemical parameter like CBC, ESR, CRP, Troponin, Liver function test, Renal function test at base line.

•1.Hypersensitivity to active ingredients or to any of the excipients of drug
•2.Patients with Severe respiratory/cardiac/renal/hepatic dysfunction which may require ventilator (CIPAP/BIPAP) or other interventional support.

发起方

Gujarat University